Loading...
Anthem Biosciences Limited IPO Details – Price, Date, GMP & Analysis
Listed
Mainboard
Price Range:
Rs.570.00
Issue Size:
Rs.3,395.00 Cr
Lot Size:
26 shares
Open Date:
July 14
Anthem Biosciences Limited IPO Overview
Bidding Dates
July 14 - July 16
Min Investment
₹14,820
Price Range
₹570.00
Issue Size
₹3,395.00 Cr
IPO DRHP Doc
Company Overview
Anthem Biosciences Limited, incorporated in 2006, is a technology-focused Contract Research, Development, and Manufacturing Organization (CRDMO) specializing in drug discovery, development, and manufacturing processes. The company serves a diverse clientele, including biotech firms and large pharmaceutical companies globally, and manufactures specialized fermentation-based APIs such as probiotics and enzymes. As of September 30, 2024, Anthem Biosciences had 196 projects and over 425 customers across 44 countries. The company holds one patent in India and seven overseas, with 24 pending global patent applications. Its team comprises 600 employees with expertise in various scientific fields.
IPO Timeline
Opens
Jul 14
Closes
Jul 16
Allotment
Jul 17
Refunds
Jul 18
Shares Credit
Jul 18
Listing
Jul 21
Opens
Jul 14
Closes
Jul 16
Allotment
Jul 17
Refunds
Jul 18
Shares Credit
Jul 18
Listing
Jul 21
Latest Subscription Data
| Category | Subscription | Status |
|---|---|---|
| QIB (Qualified Institutional Buyers) | 192.80x | Oversubscribed |
| NII (Non-Institutional Investors/HNI) | 44.70x | Oversubscribed |
| RII (Retail Individual Investors) | 5.98x | Oversubscribed |
| Total Subscription | 67.42x | Oversubscribed |
Last updated: Jul 16, 2025, 05:01 PM
Current GMP:
Rs.179
Est. Listing:
Rs.749
Est. Gain:
+31.4%
Star Rating:
★★★★★(4/5)
Financial Information
Financial Data Table
Detailed breakdown of financial metrics across years
| Financial Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Assets | ₹2,807.58 Cr | ₹2,398.11 Cr | ₹2,014.46 Cr |
| EBITDA | ₹683.78 Cr | ₹519.96 Cr | ₹446.05 Cr |
| Net Worth | ₹2,409.86 Cr | ₹1,924.66 Cr | ₹1,740.67 Cr |
| Profit After Tax | ₹451.26 Cr | ₹367.31 Cr | ₹385.19 Cr |
| Reserves and Surplus | ₹2,298.05 Cr | ₹1,815.39 Cr | ₹1,628.88 Cr |
| Revenue | ₹1,930.29 Cr | ₹1,483.07 Cr | ₹1,133.99 Cr |
| Total Borrowing | ₹108.95 Cr | ₹232.53 Cr | ₹125.06 Cr |
Financial data is visualized in the chart above
Strengths & Risks Analysis
Key Strengths
Competitive advantages and positive aspects
- Comprehensive services across the drug life cycle for small molecules and biologics
- Focus on advanced solutions across modalities and manufacturing practices
- Specialised model for small pharmaceutical and biotech companies
- Established customer base with ongoing relationships
- Experienced leadership and skilled scientific team
IPO Details
Anthem Biosciences IPO Details
| ₹50.00 | |
| Face Value | ₹2 per share |
| IPO Date | July 14, 2025 to July 16, 2025 |
| Issue Price | ₹570 per share |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Listing Date | July 21, 2025 |
| Lot Size | 26 Shares |
| Sale Type | Offer For Sale |
| Share Holding Post Issue | 56,16,10,051 shares |
| Share Holding Pre Issue | 56,16,10,051 shares |
| Total Issue Size | 5,95,75,319 shares (aggregating up to ₹3,395.79 Cr) |
Anthem Biosciences IPO Reservation
Share Reservation Distribution
QIB
29,708,332 shares (49.87%)
Retail
20,795,834 shares (34.91%)
Anchor Investors
17,824,999 shares (29.92%)
QIB (Ex-Anchor)
11,883,333 shares (19.95%)
HNI (NII)
8,912,500 shares (14.96%)
bNII (>₹10L)
5,941,667 shares (9.97%)
sNII (<₹10L)
2,970,833 shares (4.99%)
Employee
158,653 shares (0.27%)
Anthem Biosciences IPO Promoter Holding
| Share Holding Post Issue | 74.68% |
| Share Holding Pre Issue | 76.87% |
Anthem Biosciences IPO Listing Details
| ₹570 per share |
| 544449 |
| ANTHEM |
| B |
| EQ |
| INE0CZ201020 |
| July 21, 2025 |
Key Dates
Open Date:July 14
Close Date:July 16
Listing Date:July 21
